期刊文献+

不同大鼠胶质瘤抗原致敏的DC体外诱导CTL活性的研究 被引量:10

Induction of tumor-specific cytotoxic T lymphocytes in vitro by dendritic cells pulsed with different glioma antigens
下载PDF
导出
摘要 目的 :比较大鼠骨髓来源的树突状细胞 (dendriticcells,DC)体外经由大鼠C6胶质瘤细胞由不同方式制备的不同抗原致敏后 ,对特异性细胞毒性T淋巴细胞 (cytotoxicTlymphocyte ,CTL)的诱导作用。方法 :自大鼠骨髓分离DC前体细胞 ,经重组大鼠粒细胞巨噬细胞集落刺激因子 (rrGM -CSF) +白细胞介素 4 (rrIL - 4 )诱导培养、扩增 ;由C6胶质瘤细胞经由反复冻融、煮沸灭活及超声破碎细胞抽提其总蛋白的方法制备各种不同抗原致敏DC ,致敏的DC与T淋巴细胞进行共培养诱导CTL ;以ELISA法检测CTL诱导过程中淋巴细胞趋化因子 (lymphocytechemoattractantfactor)及细胞因子IFN -γ分泌水平 :以 [3 H]-TdR掺入法检测DC诱导T细胞增殖及其特异性CTL杀伤活性。结果 :体外应用煮沸灭活瘤细胞制备的肿瘤抗原致敏DC ,能诱导更强的刺激T细胞增殖的能力、并且可以诱导杀伤活性更强的CTL。结论 :应用煮沸灭活的瘤细胞制备瘤抗原负载DC获得瘤苗可获得更强的抗肿瘤保护作用。 AIM: The goal of this study was to compare different methods for tumor antigen preparation, to observe the induction of tumor-specific cytotoxic T lymphocytes in rats by dendritic cells (DCs) pulsed with different tumor antigens. METHODS: The precursors of dendritic cells were isolated from bone marrow of rats, stimulated in vitro with recombinent rat granulocyte-macrophage colony-stimulating factor (rrGM-CSF) and interleukin-4 (rrIL-4). Then rat DCs were pulsed with C6 tumor cell antigens prepared with different methods: freeze-thaw, boiling or total protein extracted from ultrasonic crushed tumor cell. Subsequently primed DCs were cocultured with T lymphocytes isolated from spleen to induce CTL. Lymphocyte chemoattractant factor from DCs and cytokine IFN-γ release were determined by ELISA, the cytotoxicity of CTL was assayed by JAM test. RESULTS: DCs pulsed with boiled tumor cell in vitro induced an enhanced ability of T-cell proliferation and cytotoxic T lymphocyte activity.CONCLUSION: Our results demonstrated that DCs primed with boiled tumor cell may represent a method for inducing immune responses against the entire repertoire of tumor antigens of malignancies.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2004年第4期584-589,共6页 Chinese Journal of Pathophysiology
关键词 树突细胞 神经胶质瘤 T淋巴细胞 细胞毒性 Dendritic cells Glioma T-lymphocyte, cytotoxic
  • 相关文献

参考文献29

  • 1黄幼田,董子明,赵明耀,杨洪艳,张义国,郑智敏,马俊芬,汤黎明,陈宁.小鼠骨髓树突状细胞pcDNA3-hCEA转染疫苗的抗瘤作用[J].中国病理生理杂志,2002,18(11):1317-1323. 被引量:4
  • 2古涛,朱一蓓,李敏,黄勇,席泓,于葛华,戴俊,顾宗江,张学光.肿瘤细胞冻融裂解物上清对凋亡细胞负载的树突状细胞生物学特性的作用研究[J].中国病理生理杂志,2003,19(3):301-304. 被引量:11
  • 3孙晓东,刘杏娥,吴金民.人黑色素瘤抗原-3冲击的树突状细胞诱导抗肿瘤免疫应答[J].中国病理生理杂志,2003,19(5):615-618. 被引量:5
  • 4Banchereau J, Steinman RM. Dendritic cells and the control of immunity[J]. Nature, 1998, 392:245-252.
  • 5Linda M, Liau MD, Keith L, et al. Treatment of intracranial gliomas with bone marrow- derived dendritic cells pulsed with tumor antigens[J]. J Neurosurg, 1999, 90(6) : 1115 - 1124.
  • 6Tjoa BA, Elgamal AA, Murphy GP, et al. Vaccine therapy for prostate canccr[J]. Urol Clin North Am, 1999,26(2) :365 -374.
  • 7Yoshida S, Morii K, Watanabe M, et al. The generation of anti- tumoral cells using dendritic cells from the peripheral blood of patients with malignant brain tumors[J]. Cancer Immunol Immunother, 2001,50(6) :321 - 327.
  • 8Schnurr M, Galambos P, Scholz C, et al. Tumor cell lysate-pulsed human dendritic cells induce a T - cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines[J]. Cancer Res, 2001,61 ( 17 ) :6445- 6450.
  • 9Ashley DM, Faiola B, Nair S,et al. Bone nmrtDw- generated dendritic cells pulsed with tumor extracts or tumor RNA induced antitumor immunity against central nervous system tumors[J]. J Exp Med, 1997, 186(7):1177- 1182.
  • 10Yu JS, Wheeler CJ, Zeltzer PM, et al. Vaccination of malignant glioma patients with peptide- pulsed dendritic cells elicits systemic cytotoxicity and intracranial T- cell infiltration[ J ].Cancer Res, 2001, 61(3):842-847.

二级参考文献20

  • 1顾子颖 王海林(译).精编分子生物学实验指南(第1版)[M].北京:科学出版社,1998.286.
  • 2Tahara K, Mori M, Sadanaga N, et al. Expression of the MAGE gene family in human hepatocelar carcinoma[J]. Cancer, 1999, 85(6): 1234-1240.
  • 3Chen CH, Huang GT, Lee HS, et al. High frequency of expression of MAGE genes in human hepatocellular carcinoma[J]. Liver, 1999,19(2):110-114.
  • 4Melief CJ, Toes RE, Medema JP, et al. Strategies for immunotherapy of cancer[J]. Adv Immunol, 2000,75: 235-282.
  • 5Chaux P, Vantomme V, Stroobant V, et al. Identification of MAGE- 3 epitopes presented by HLA- DR molecules to CD4^+ T lymphocytes[Jl. J Exp Med, 1999,189(5): 767-777.
  • 6Manici S, Stumiolo T, Imro MA, et al. Melanoma cells present a MAGE- 3 epitope to CD4^+ cytotoxic T cells in association with histocompatibility leukocyte antigen DR11[J]. J Exp Med, 1999, 189(5): 871- 876.
  • 7Miconnet I, Servis C, Cerottini JC, et al. Amino acid identity and/or position determines the proteasomal cleavage of the HLA- A 0201 -restricted peptide tumor antigen MAGE- 3 271 - 279[J]. J Bio Chem, 2000,275(35) : 26892- 26897.
  • 8Eifuku R, Takenoyama M, Yoshino I, et al. Analysis of MAGE- 3 drived synthetic peptide as a human lung cancer antigen recognized by cytotoxic T lymphocytes[J]. Int J Clin Oncol, 2001,6(1): 34-39.
  • 9Schuler G, Steinmam RM. Dendritic cells as adjuvants for immune-mediated resistance to tumors[J]. J Exp Med, 1997,186(8): 1183- 1187.
  • 10Toungouz M, Lambermont M, Velu T, et al. Anti- tumor immunotherapy based on dendritic cells [ J ]. J Soc Biol,2001,195(1): 19-23.

共引文献18

同被引文献80

引证文献10

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部